Molecular Designs secures first FDA clearance for SimplicityDx Panel FluA/FluB/RSV assay
View as a Web Page
News Medical
 
  Pulmonology Pulmonology logo  
  The latest pulmonology news from News Medical  
 Biologic drug offers promising protection against alpha-gal syndromeBiologic drug offers promising protection against alpha-gal syndrome
 
The summer of 2026 was a particularly bad season for ticks. And with it came a rising number of cases of alpha-gal syndrome (AGS) thanks to bites from the Lone Star Tick.
 
 
 Molecular Designs secures first FDA clearance for SimplicityDx Panel FluA/FluB/RSV assayMolecular Designs secures first FDA clearance for SimplicityDx Panel FluA/FluB/RSV assay
 
Molecular Designs, a physician-founded developer and manufacturer of molecular infectious disease assays, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K262789) for its SimplicityDx Panel FluA/FluB/RSV, the company's first FDA-cleared assay.
 
   Stocking epinephrine in schools protects students and eases family financial burdensStocking epinephrine in schools protects students and eases family financial burdens
 
For school kids with severe food allergies, having epinephrine on hand at school can mean the difference between a scary moment and a life-threatening one.
 
   Scientists identify metabolic pathway driving lung cancer lymph node metastasisScientists identify metabolic pathway driving lung cancer lymph node metastasis
 
Metabolic reprogramming plays a critical role in shaping the adaptive capabilities of malignant cells during dissemination.
 
   Extended lymph node dissection shows no higher surgical risk in stage IV gastric cancerExtended lymph node dissection shows no higher surgical risk in stage IV gastric cancer
 
A research team led by Professor Jae-Seok Min of the Division of Foregut Surgery, Department of Surgery, at Korea University Anam Hospital and Professor Sang-Ho Jeong of the Department of Surgery at Gyeongsang National University Changwon Hospital examined the association between lymph node dissection and short-term outcomes after palliative, non-curative gastrectomy for stage IV gastric cancer.
 
 Study identifies two proteins involved in toxin-related pulmonary hypertension
 
Study identifies two proteins involved in toxin-related pulmonary hypertensionA research team has identified two proteins that may help explain how a plant toxin damages the arteries that carry blood to the lungs.
 
 
 New statement highlights urgent need to improve veterans' heart health
 
New statement highlights urgent need to improve veterans' heart healthFewer than 5% of U.S. military veterans may achieve optimal cardiovascular health based on the American Heart Association's Life's Essential 8™ metrics, highlighting an urgent opportunity to improve prevention and help veterans live longer, healthier lives, according to a new scientific statement published today in the Association's flagship journal, Circulation.
 
 
 New method maps CRISPR off-target edits at single-cell resolution
 
New method maps CRISPR off-target edits at single-cell resolutionA new era of genome research began in 2012 with the discovery that CRISPR/Cas9 could function as molecular scissors to cut specific DNA sequences.
 
 
 Broad genomic sequencing extends survival in advanced lung cancer patients
 
Broad genomic sequencing extends survival in advanced lung cancer patientsNew research in the November 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that patients with advanced non-small cell lung cancer (NSCLC) lived longer when they received broad-based genomic sequencing (BGS)-testing a large panel of dozens or hundreds of genes at once-before starting treatment, compared with patients who received more limited biomarker testing of just one or two genes.
 
 
 Inhaled living medicine reduces drug-resistant lung biofilms in the lungs of pigs
 
Inhaled living medicine reduces drug-resistant lung biofilms in the lungs of pigsA "living medicine" has thinned biofilms of antibiotic-resistant Pseudomonas aeruginosa in the lungs of pigs, according to the findings of a study published today in the journal eBioMedicine.
 
 
 Early-life environmental exposures linked to multiple health outcomes into adolescence
 
Early-life environmental exposures linked to multiple health outcomes into adolescenceEnvironmental exposures during pregnancy and childhood can be associated with multiple aspects of health at the same time, with many of these associations persisting into adolescence health, according to a new study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, and in collaboration with the French National Institute for Health and Medical Research (Inserm).
 
 
 Vaping frequency linked to declining lung function in young adults
 
Vaping frequency linked to declining lung function in young adultsLong term vaping in young people may induce persistent changes in lung function, suggest preliminary findings published online in the journal Tobacco Control.
 
 
 Language barriers delay early peanut introduction for many infants
 
Language barriers delay early peanut introduction for many infantsFeeding peanut products to infants early in life is one of the best tools doctors have to help prevent peanut allergy.
 
 
 Unusual allergy triggers cause anaphylaxis in children and teenagers
 
Unusual allergy triggers cause anaphylaxis in children and teenagersWhen people think about anaphylaxis, peanuts, shellfish, or even bee sting often come to mind. Three medically challenging cases presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2026 Annual Scientific Meeting show that severe allergic reactions can come from far less obvious places: a fish ingredient hidden in an energy drink, a natural hair oil and a popular children's sensory toy.
 
 
 Drug combination shows long-term survival in advanced thymic cancer
 
Drug combination shows long-term survival in advanced thymic cancerFinal results from the phase 2 PECATI clinical trial demonstrate encouraging long-term survival outcomes with the combination of lenvatinib and pembrolizumab in patients with previously treated advanced B3-thymoma and thymic carcinoma.
 
 
 Clinical trial of triple combination therapy reveals clues to lung cancer treatment resistance
 
Clinical trial of triple combination therapy reveals clues to lung cancer treatment resistanceIn a new clinical trial, researchers have interrogated how patients with an aggressive form of lung cancer respond to treatment with a triple combination therapy.
 
 
 Biologic drug for eosinophilic esophagitis lowers childhood asthma risk
 
Biologic drug for eosinophilic esophagitis lowers childhood asthma riskYoung children treated for eosinophilic esophagitis (EoE) with dupilumab (a biologic medication) were less likely to develop asthma in the future compared with children who received a different treatment.
 
 
 Study reveals frequent insurance denials for pediatric biologic allergy treatments
 
Study reveals frequent insurance denials for pediatric biologic allergy treatmentsWhen a child's severe asthma, eczema, hives, or food allergy isn't under control, an allergist may prescribe a newer type of medicine called a biologic.
 
 
 Enterprise Therapeutics granted EMA orphan medicinal product designation for novel cystic fibrosis therapy, ETD001
 
Enterprise Therapeutics granted EMA orphan medicinal product designation for novel cystic fibrosis therapy, ETD001Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has granted ETD001 designation as an orphan medicinal product for the treatment of cystic fibrosis.
 
 
 Strengthening mucosal immunity could improve protection against respiratory infections
 
Strengthening mucosal immunity could improve protection against respiratory infectionsA review published in Genes & Diseases highlights how strengthening immunity in the nose and airways could improve protection against respiratory infections.
 
 
 Clinicians continue ordering food allergy panels despite false positive risks
 
Clinicians continue ordering food allergy panels despite false positive risksNew research being presented at the 2026 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) showed many clinicians in a survey knew that food allergy panel testing often results in false positives- yet they kept ordering it anyway.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney

Copyright © 2000-2026